These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21761347)

  • 1. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.
    Jiang S; Katayama H; Wang J; Li SA; Hong Y; Radvanyi L; Li JJ; Sen S
    Horm Cancer; 2010 Feb; 1(1):11-20. PubMed ID: 21761347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.
    Katayama H; Sen S
    Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
    McCune K; Bhat-Nakshatri P; Thorat MA; Nephew KP; Badve S; Nakshatri H
    Cancer Res; 2010 Jan; 70(2):685-96. PubMed ID: 20068169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
    D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
    Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).
    Qi J; Huo L; Zhu YT; Zhu YJ
    J Biol Chem; 2014 Nov; 289(45):31373-81. PubMed ID: 25258321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo S; Sonenshein GE
    Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
    Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
    Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
    Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
    Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
    Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
    Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
    Siggelkow W; Boehm D; Gebhard S; Battista M; Sicking I; Lebrecht A; Solbach C; Hellwig B; Rahnenführer J; Koelbl H; Gehrmann M; Marchan R; Cadenas C; Hengstler JG; Schmidt M
    BMC Cancer; 2012 Nov; 12():562. PubMed ID: 23186136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.
    Eeckhoute J; Keeton EK; Lupien M; Krum SA; Carroll JS; Brown M
    Cancer Res; 2007 Jul; 67(13):6477-83. PubMed ID: 17616709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
    Ding Y; Liu Y; Lee DK; Tong Z; Yu X; Li Y; Xu Y; Lanz RB; O'Malley BW; Xu J
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.
    Wang Y; Zhou D; Phung S; Masri S; Smith D; Chen S
    Mol Endocrinol; 2011 Jan; 25(1):72-82. PubMed ID: 21084382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
    Bouchard MF; Taniguchi H; Viger RS
    Endocrinology; 2005 Nov; 146(11):4905-16. PubMed ID: 16109788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
    Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.